Search for other papers by Lena-Maria Levin in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Greifswald, Germany
DZD (German Center for Diabetes Research), Greifswald, Germany
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Markus M Lerch in
Google Scholar
PubMed
Institute and Policlinic for Radiology and Interventional Radiology, University Hospital, Carl-Gustav-Carus University Dresden, Dresden, Germany
Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Greifswald, Germany
Search for other papers by Nele Friedrich in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Greifswald, Germany
Search for other papers by Stephanie Zylla in
Google Scholar
PubMed
Introduction In industrialized countries, the prevalence and incidence of hepatic steatosis have steadily increased over the past decades ( 1 ). Besides excessive alcohol consumption, obesity and other metabolic disorders have been frequently
Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China
Search for other papers by Xu Chen in
Google Scholar
PubMed
Search for other papers by Yi Tang in
Google Scholar
PubMed
Search for other papers by Shen Chen in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China
Search for other papers by Wenhua Ling in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China
Search for other papers by Qing Wang in
Google Scholar
PubMed
can be further mined to identify hub genes that can be targeted to treat hepatic steatosis. In this study, we combined two public datasets which have full histological data to identify differentially expressed genes (DEGs) between SS and healthy
Search for other papers by Helle Keinicke in
Google Scholar
PubMed
Search for other papers by Gao Sun in
Google Scholar
PubMed
Search for other papers by Caroline M Junker Mentzel in
Google Scholar
PubMed
Search for other papers by Merete Fredholm in
Google Scholar
PubMed
Search for other papers by Linu Mary John in
Google Scholar
PubMed
Search for other papers by Birgitte Andersen in
Google Scholar
PubMed
Search for other papers by Kirsten Raun in
Google Scholar
PubMed
Search for other papers by Marina Kjaergaard in
Google Scholar
PubMed
has multiple effects on the liver either by direct or indirect actions ( 11 ). For instance, FGF21 has been shown to reduce hepatic steatosis through increased fatty acid (FA) oxidation and decreased lipogenesis in rodents ( 11 ). Moreover, an FGF21
Search for other papers by Silan Zheng in
Google Scholar
PubMed
Search for other papers by Meifeng Tong in
Google Scholar
PubMed
Search for other papers by Lianqin Dong in
Google Scholar
PubMed
Search for other papers by Chunmin Du in
Google Scholar
PubMed
Search for other papers by Xin Zheng in
Google Scholar
PubMed
Search for other papers by Liying Wang in
Google Scholar
PubMed
Search for other papers by Peiying Huang in
Google Scholar
PubMed
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Mingzhu Lin in
Google Scholar
PubMed
The School of Clinical Medicine, Fujian Medical University, Fuzhou, China
Search for other papers by Changqin Liu in
Google Scholar
PubMed
most common forms of liver diseases, which is typically characterized by more than 5% accumulation of hepatocellular lipids and comprises a spectrum of disease stages ranging from simple hepatic steatosis (HS) to nonalcoholic steatohepatitis (NASH) ( 4
Search for other papers by Stephen J Winters in
Google Scholar
PubMed
Search for other papers by Charles R Scoggins in
Google Scholar
PubMed
Search for other papers by Duke Appiah in
Google Scholar
PubMed
Search for other papers by Dushan T Ghooray in
Google Scholar
PubMed
linoleic (18:2), stearic (18:0), arachidonic (20:4), palmitoleic (16:1) and myristic (14:0) acids ( Table 1 ). Table 1 Clinical characteristics and hepatic fatty acid composition in individuals with steatosis compared to the low-fat group
Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Aleksandra Maria Polak in
Google Scholar
PubMed
Search for other papers by Anna Krentowska in
Google Scholar
PubMed
Search for other papers by Agnieszka Łebkowska in
Google Scholar
PubMed
Search for other papers by Justyna Hryniewicka in
Google Scholar
PubMed
Search for other papers by Monika Leśniewska in
Google Scholar
PubMed
Search for other papers by Irina Kowalska in
Google Scholar
PubMed
as in patients with coronary artery disease, in comparison to healthy controls ( 14 ). Fetuin-B appears to be a hepatokine that becomes dysregulated in hepatic steatosis and insulin resistance. However, no evidence regarding the association between
Search for other papers by Tatsuya Kondo in
Google Scholar
PubMed
Search for other papers by Nobukazu Miyakawa in
Google Scholar
PubMed
Search for other papers by Sayaka Kitano in
Google Scholar
PubMed
Search for other papers by Takuro Watanabe in
Google Scholar
PubMed
Search for other papers by Rieko Goto in
Google Scholar
PubMed
Search for other papers by Mary Ann Suico in
Google Scholar
PubMed
Search for other papers by Miki Sato in
Google Scholar
PubMed
Search for other papers by Yuki Takaki in
Google Scholar
PubMed
Search for other papers by Masaji Sakaguchi in
Google Scholar
PubMed
Search for other papers by Motoyuki Igata in
Google Scholar
PubMed
Search for other papers by Junji Kawashima in
Google Scholar
PubMed
Search for other papers by Hiroyuki Motoshima in
Google Scholar
PubMed
Search for other papers by Takeshi Matsumura in
Google Scholar
PubMed
Search for other papers by Hirofumi Kai in
Google Scholar
PubMed
Search for other papers by Eiichi Araki in
Google Scholar
PubMed
from simple hepatic steatosis to its inflammatory variant, nonalcoholic steatohepatitis (NASH); progressive fibrosis; cirrhosis and eventually hepatocellular carcinoma in the absence of significant alcohol consumption. NAFLD is considered an important
Search for other papers by Xiaonan Guo in
Google Scholar
PubMed
Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Search for other papers by Xiaorui Lyu in
Google Scholar
PubMed
Search for other papers by Hanyuan Xu in
Google Scholar
PubMed
Search for other papers by Huijuan Zhu in
Google Scholar
PubMed
Search for other papers by Hui Pan in
Google Scholar
PubMed
Search for other papers by Linjie Wang in
Google Scholar
PubMed
Search for other papers by Hongbo Yang in
Google Scholar
PubMed
Search for other papers by Fengying Gong in
Google Scholar
PubMed
/dw rats to explore the characterizations of hepatic metabolic profiles and their relationship with liver function. We found that (1) dw/dw rats represented reduced serum IGF-1 levels, increased AST and ALT levels, and more obvious hepatic steatosis
Search for other papers by Frederique Van de Velde in
Google Scholar
PubMed
Search for other papers by Marlies Bekaert in
Google Scholar
PubMed
Search for other papers by Anja Geerts in
Google Scholar
PubMed
Search for other papers by Anne Hoorens in
Google Scholar
PubMed
Search for other papers by Arsène-Hélène Batens in
Google Scholar
PubMed
Search for other papers by Samyah Shadid in
Google Scholar
PubMed
Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Duesseldorf, Leibniz Center for Diabetes Research, Duesseldorf, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Search for other papers by Margriet Ouwens in
Google Scholar
PubMed
Search for other papers by Yves Van Nieuwenhove in
Google Scholar
PubMed
Search for other papers by Bruno Lapauw in
Google Scholar
PubMed
. Recent experimental work suggested that excess accumulation of diacylglycerol (DAG) in hepatocytes, rather than hepatic steatosis per se (intrahepatic triglyceride (TG) content), is the main molecular mechanism of development of IR ( 7 , 8 ). Until now
Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Search for other papers by Robert Maidstone in
Google Scholar
PubMed
Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, UK
Search for other papers by Martin K Rutter in
Google Scholar
PubMed
Oxford Liver Unit, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, UK
Search for other papers by Thomas Marjot in
Google Scholar
PubMed
NIHR Oxford Health Biomedical Research Centre, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Search for other papers by David W Ray in
Google Scholar
PubMed
NIHR Oxford Health Biomedical Research Centre, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Search for other papers by Matthew Baxter in
Google Scholar
PubMed
.1 Depression (%) 4.63 5.09 4.72 Cardiovascular disease (%) 3.72 4.24 4 Dallas steatosis index (DSI) −2.65 (1.39) −2.42 (1.42) −2.26 (1.4) Data are mean ( s.d. ) or percentages. DSI (Dallas steatosis index) is defined in